Earnings · China A-shares
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. Class A (301096) earnings
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -1433.26% year on year, -684.81% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +3.84% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -1433.26%
- Excl. one-offs YoY
- -684.81%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.80% | — |
| 3 days | +3.84% | — |
| 7 days | +2.51% | — |
| 14 days | -9.42% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +1.23%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥81.65M | -1433.26% | — | -11.78% | -0.75 | -3.33% | +3.84% | — | — |
| 2026 interim report | 2026-08-27 | ¥1.60M | -48.43% | -83.30% | -8.40% | 0.01 | 0.06% | -0.73% | -12.61% | -3.68% |
| 2026 Q1 report | 2026-04-24 | ¥12.81M | +148.91% | +121.28% | +24.65% | 0.12 | 0.51% | -1.24% | +0.93% | +0.51% |
| 2025 annual report | 2026-04-24 | -¥90.40M | -71.39% | -41.96% | -15.45% | -0.83 | -3.57% | -1.24% | +0.93% | +0.51% |
| 2025 Q3 report | 2025-10-25 | ¥6.12M | -95.68% | — | -29.33% | 0.06 | 0.24% | +0.21% | -5.02% | -4.79% |
| 2025 interim report | 2025-08-27 | ¥3.10M | -97.69% | — | -36.70% | 0.03 | 0.12% | +2.69% | +5.51% | +1.73% |
| 2025 Q1 report | 2025-04-23 | -¥26.20M | -152.59% | — | -40.32% | -0.24 | -1.02% | +2.61% | +41.82% | +38.78% |
| 2024 annual report | 2025-04-23 | -¥52.74M | -119.39% | — | -21.18% | -0.49 | -2.01% | +2.61% | +41.82% | +38.78% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 301096 · Stock news: 301096
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.